- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 362473, 8 pages
Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Therapy Promotes Functional Recovery of Contused Rat Spinal Cord through Enhancement of Endogenous Cell Proliferation and Oligogenesis
1Institute of Catholic Integrative Medicine (ICIM), Incheon St. Mary's Hospital, The Catholic University of Korea, Incheon, Republic of Korea
2Department of Neurosurgery, The Catholic University of Korea, Seoul, Republic of Korea
3Medipost Biomedical Research Institute, Medipost Co., Ltd., Seoul, Republic of Korea
Received 23 June 2011; Accepted 29 September 2011
Academic Editor: Ken-ichi Isobe
Copyright © 2012 Sang In Park et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citations to this Article [6 citations]
The following is the list of published articles that have cited the current article.
- Jin Zhou, Guoping Tian, Jinge Wang, Xiaoguang Luo, Siyang Zhang, Jianping Li, Li Li, Bing Xu, Feng Zhu, Xia Wang, Chunhong Jia, Weijin Zhao, Danyang Zhao, and Aihua Xu, “Neural cell injury microenvironment induces neural differentiation of human umbilical cord mesenchymal stem cells,” Neural Regeneration Research, vol. 7, no. 34, pp. 2689–2697, 2012.
- Dorothée Cantinieaux, Renaud Quertainmont, Silvia Blacher, Loïc Rossi, Thomas Wanet, Agnès Noël, Gary Brook, Jean Schoenen, and Rachelle Franzen, “Conditioned Medium from Bone Marrow-Derived Mesenchymal Stem Cells Improves Recovery after Spinal Cord Injury in Rats: An Original Strategy to Avoid Cell Transplantation,” PLoS ONE, vol. 8, no. 8, 2013.
- Yu Zeng, Mingqiang Rong, Yunsheng Liu, Jingfang Liu, Ming Lu, Xiaoyu Tao, Zhenyan Li, Xin Chen, Kui Yang, and Chuntao Li, “Electrophysiological Characterisation of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Induced by Olfactory Ensheathing Cell-Conditioned M edium,” Neurochemical Research, vol. 38, no. 12, pp. 2483–2489, 2013.
- Yi Ren, and Wise Young, “Managing Inflammation after Spinal Cord Injury through Manipulation of Macrophage Function,” Neural Plasticity, vol. 2013, pp. 1–9, 2013.
- Reaz Vawda, and Michael G. Fehlings, “Mesenchymal cells in the treatment of spinal cord injury: Current & future perspectives,” Current Stem Cell Research and Therapy, vol. 8, no. 1, pp. 25–38, 2013.
- Dae-Hyun Roh, Min-Soo Seo, Hoon-Seong Choi, Sang-Bum Park, Ho-Jae Han, Alvin J. Beitz, and Jang-Hern Lee, “Transplantation of Human Umbilical Cord Blood or Amniotic Epithelial Stem C ells Alleviates Mechanical Allodynia After Spinal Cord Injury in Rats,” Cell Transplantation, vol. 22, no. 9, pp. 1577–1590, 2013.